Pfenex Public
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
%20.jpg)
%20.jpg)
Investor Type:
N/A
Technology:
Cancer
Investment Stage:
N/A
Estimated Revenue:
$10M to $50M
Founded Date:
2009
Industry:
PharmTech
Employee Number:
11-50
Funding Status:
M&A
Number Of Exists:
N/A
Headquarters:
San Diego, California, United States